Compounds > carbidopa, levodopa drug combination
Page last updated: 2024-08-26

carbidopa, levodopa drug combination and Dyskinesia Syndromes

carbidopa, levodopa drug combination has been researched along with Dyskinesia Syndromes in 18 studies

Research

Studies (18)

TimeframeStudies, this research(%)All Research%
pre-19908 (44.44)18.7374
1990's6 (33.33)18.2507
2000's1 (5.56)29.6817
2010's3 (16.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Băjenaru, O; Buraga, I; Constantinescu, A; Ene, A; Mureşan, DF; Perju-Dumbrava, L; Popescu, BO; Popescu, CD; Sabău, M; Simu, M; Szász, JA1
Hattori, N1
Armstrong, J; Artuch, R; Barredo-Valderrama, E; Campistol, J; Castro de Castro, P; Cormand, B; Garcia-Cazorla, A; Ormazabal, A; Serrano, M; Toma, C1
Gadkary, CA; Mummaneni, PV; Quinones-Hinojosa, A; Rosenberg, WS1
Brin, IL; Drozdov, AZ; Filatova, TS; Kogan, BM; Kovaleva, IA1
Bennett, JP; Schuh, LA1
Horstink, MW; Jansen, EN; Roos, RA; Wolters, EC1
Blaney, TJ; Chandonait, SE; Emerich, DF; Lindner, MD; Mullins, TD; Plone, MA; Sherman, SS; Stott, JA; Winn, SR1
Hempel, AG; Maaty, MA; Sage, JI; Wagner, ML1
Adamkov, J; Drobný, M; Fundárek, J; Svaleková, A1
Marsden, CD; Pires, M; Quinn, NP; Scaravilli, F; Steiger, MJ1
Deleu, D; Ebinger, G; Jacques, M; Michotte, Y1
Gilley, DW; Goetz, CG; Klawans, HL; Tanner, CM1
Dickins, QS; Dobson, J; Rodnitzky, RL1
Bush, DF; Hutton, JT; Liss, CL; Morris, JL; Reines, S; Smith, ME1
Reynolds, CM; Riklan, M; Stellar, S1
Bioulac, B; Doudet, D; Gross, C; Lebrun-Grandié, P1
Calne, DB; Jaffe, M; Larsen, TA; LeWitt, PA; Newman, RP1

Reviews

1 review(s) available for carbidopa, levodopa drug combination and Dyskinesia Syndromes

ArticleYear
Movement disorders: advances in 2015.
    The Lancet. Neurology, 2016, Volume: 15, Issue:1

    Topics: Animals; Antiparkinson Agents; Carbidopa; DNA-Binding Proteins; Drug Combinations; Humans; Levodopa; Mitochondrial Proteins; Movement Disorders; Parkinson Disease; Transcription Factors

2016

Trials

4 trial(s) available for carbidopa, levodopa drug combination and Dyskinesia Syndromes

ArticleYear
Superior clinical efficacy of Sinement CR 50/200 versus Sinemet 25/100 in patients with fluctuating Parkinson's disease. An open and a double-blind, double-dummy, multicenter treatment evaluation. Dutch Sinement CR Study Group.
    Advances in neurology, 1993, Volume: 60

    Topics: Antiparkinson Agents; Carbidopa; Disability Evaluation; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Humans; Levodopa; Movement Disorders; Muscle Rigidity; Neurologic Examination; Parkinson Disease

1993
Pharmacoeconomic analysis of using Sinemet CR over standard Sinemet in parkinsonian patients with motor fluctuations.
    The Annals of pharmacotherapy, 1998, Volume: 32, Issue:9

    Topics: Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Carbidopa; Cost-Benefit Analysis; Delayed-Action Preparations; Drug Combinations; Female; Humans; Levodopa; Male; Middle Aged; Movement Disorders; Parkinson Disease; Prospective Studies

1998
Multicenter controlled study of Sinemet CR vs Sinemet (25/100) in advanced Parkinson's disease.
    Neurology, 1989, Volume: 39, Issue:11 Suppl 2

    Topics: Aged; Antiparkinson Agents; Carbidopa; Delayed-Action Preparations; Double-Blind Method; Drug Combinations; Female; Humans; Levodopa; Male; Movement Disorders; Multicenter Studies as Topic; Parkinson Disease; Randomized Controlled Trials as Topic

1989
Motor function in the normal aging population: treatment with levodopa.
    Neurology, 1985, Volume: 35, Issue:4

    Topics: Aged; Aging; Carbidopa; Dopamine; Drug Combinations; Humans; Levodopa; Middle Aged; Movement; Movement Disorders; Parkinson Disease

1985

Other Studies

13 other study(ies) available for carbidopa, levodopa drug combination and Dyskinesia Syndromes

ArticleYear
The effect of levodopa-carbidopa intestinal gel infusion long-term therapy on motor complications in advanced Parkinson's disease: a multicenter Romanian experience.
    Journal of neural transmission (Vienna, Austria : 1996), 2016, Volume: 123, Issue:4

    Topics: Adult; Aged; Antiparkinson Agents; Carbidopa; Drug Combinations; Female; Gastric Bypass; Gels; Humans; Levodopa; Male; Middle Aged; Movement Disorders; Parkinson Disease; Quality of Life; Retrospective Studies; Romania

2016
Deletion in the tyrosine hydroxylase gene in a patient with a mild phenotype.
    Movement disorders : official journal of the Movement Disorder Society, 2011, Volume: 26, Issue:8

    Topics: Antiparkinson Agents; Carbidopa; DNA Mutational Analysis; Drug Combinations; Female; Homovanillic Acid; Humans; Infant; Levodopa; Movement Disorders; Phenotype; Sequence Deletion; Tyrosine 3-Monooxygenase; Video Recording

2011
Split spinal cord malformation in an elderly patient: case report.
    Surgical neurology, 2004, Volume: 61, Issue:2

    Topics: Aged; Anticonvulsants; Antiparkinson Agents; Carbidopa; Clonazepam; Drug Combinations; Drug Therapy, Combination; Female; Humans; Levodopa; Low Back Pain; Magnetic Resonance Imaging; Movement Disorders; Spinal Dysraphism; Tomography, X-Ray Computed

2004
[Catecholamines and the dopamine-beta-hydroxylase activity of the blood plasma in motor pathology in children: the role of central and peripheral mechanisms].
    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 1994, Volume: 94, Issue:3

    Topics: Adolescent; Carbidopa; Catecholamines; Child; Chromatography, High Pressure Liquid; Dopamine Agonists; Dopamine beta-Hydroxylase; Drug Combinations; Female; Humans; Levodopa; Male; Movement Disorders; Spectrophotometry

1994
Suppression of dyskinesias in advanced Parkinson's disease. I. Continuous intravenous levodopa shifts dose response for production of dyskinesias but not for relief of parkinsonism in patients with advanced Parkinson's disease.
    Neurology, 1993, Volume: 43, Issue:8

    Topics: Aged; Antiparkinson Agents; Carbidopa; Dihydroxyphenylalanine; Dose-Response Relationship, Drug; Drug Combinations; Female; Humans; Infusions, Intravenous; Levodopa; Male; Middle Aged; Movement Disorders; Parkinson Disease; Tyrosine

1993
Somatic delivery of catecholamines in the striatum attenuate parkinsonian symptoms and widen the therapeutic window of oral sinemet in rats.
    Experimental neurology, 1997, Volume: 145, Issue:1

    Topics: Administration, Oral; Animals; Antiparkinson Agents; Apomorphine; Behavior, Animal; Carbidopa; Cell Transplantation; Disease Models, Animal; Dopamine; Drug Combinations; Drug Synergism; Levodopa; Male; Movement Disorders; Neostriatum; Parkinson Disease, Secondary; PC12 Cells; Rats; Rats, Sprague-Dawley; Rotation

1997
[Therapy of rigidity and hypokinesis in old age using Sinemet].
    Ceskoslovenska neurologie a neurochirurgie, 1979, Volume: 42, Issue:3

    Topics: Aged; Carbidopa; Drug Combinations; Female; Humans; Hydrazines; Levodopa; Male; Movement Disorders; Muscle Rigidity; Parkinson Disease, Postencephalitic; Trihexyphenidyl

1979
Hemiballism and chorea in a patient with parkinsonism due to a multisystem degeneration.
    Movement disorders : official journal of the Movement Disorder Society, 1992, Volume: 7, Issue:1

    Topics: Aged; Antiparkinson Agents; Atrophy; Brain; Carbidopa; Central Nervous System Diseases; Chorea; Diagnosis, Differential; Drug Combinations; Female; Humans; Levodopa; Movement Disorders; Nerve Degeneration; Parkinson Disease; Spinal Cord

1992
Clinical and pharmacokinetic evaluation of controlled-release levodopa/carbidopa (CR-4) in parkinsonian patients with severe motor fluctuations: a six month follow-up study.
    Clinical neurology and neurosurgery, 1989, Volume: 91, Issue:4

    Topics: Adult; Aged; Carbidopa; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Combinations; Female; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Movement Disorders; Parkinson Disease

1989
Development and progression of motor fluctuations and side effects in Parkinson's disease: comparison of Sinemet CR versus carbidopa/levodopa.
    Neurology, 1989, Volume: 39, Issue:11 Suppl 2

    Topics: Antiparkinson Agents; Carbidopa; Delayed-Action Preparations; Drug Combinations; Humans; Levodopa; Middle Aged; Movement Disorders; Parkinson Disease; Psychomotor Performance

1989
Long-term clinical efficacy of Sinemet CR in patients with Parkinson's disease.
    Neurology, 1989, Volume: 39, Issue:11 Suppl 2

    Topics: Aged; Antiparkinson Agents; Carbidopa; Delayed-Action Preparations; Drug Combinations; Follow-Up Studies; Humans; Levodopa; Middle Aged; Movement Disorders; Parkinson Disease

1989
Correlates of memory in Parkinson's disease.
    The Journal of nervous and mental disease, 1989, Volume: 177, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Amantadine; Carbidopa; Drug Combinations; Female; Humans; Levodopa; Male; Memory; Memory Disorders; Middle Aged; Movement Disorders; Neuropsychological Tests; Parkinson Disease

1989
[A model of Parkinson's disease: effect of L-dopa therapy on movement parameters and electromyographic activity in monkeys treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)].
    Comptes rendus des seances de la Societe de biologie et de ses filiales, 1985, Volume: 179, Issue:1

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Behavior, Animal; Carbidopa; Disease Models, Animal; Drug Combinations; Electromyography; Levodopa; Macaca mulatta; Movement Disorders; Parkinson Disease, Secondary; Pyridines

1985